Surgical site infections (SSIs) are hospital acquired infections of incision or organ or space that occur after surgery. The cost and challenges for treating SSIs increases because surgical patients have more complex comorbidities initially, and further there is emergence of antimicrobial-resistant pathogens. The epidemiology of SSIs is complicated due to the heterogeneous nature of these infections and varies widely among surgeons, patients, hospitals, procedures, and methods of surveillance. With day by day increase in number of surgical procedures, the occurrence of SSI is increasing.
Thus there is a necessity of public reporting of process, outcome, other quality improvement measures, and reimbursements for treating SSIs, which are reduced or denied. According to an estimation, for prevention of SSIs there should be an application of evidence-based strategies. The patients who…
